Interactions between cancer cells and the endothelium in metastasis

Journal of Pathology

Volumn 190, Issue 3, 2000, Pages 310-329

  Orr, F William ^a   Wang, H Helen ^a   Lafrenie, Robert M ^b   Scherbarth, Sandra ^a   Nance, Dwight M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Northeastern Ontario Regional Cancer Centre   (Canada)

Author keywords

Cell adhesion; Cytokine; Endothelium; Free radical; Metastasis

Indexed keywords

CELL ADHESION MOLECULE; CHEMOTACTIC FACTOR; CYTOKINE; GROWTH FACTOR; INTEGRIN; LIPID; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; SELECTIN;

ANIMAL CELL; CANCER CELL; CELL ACTIVATION; CELL ADHESION; CELL COMMUNICATION; CELL INTERACTION; CELL MIGRATION; CELL TRANSPORT; CIRCULATION; CYTOTOXICITY; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES;

EID: 0034094341     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P     Document Type: Review

References (173)

1. Weiss L, Orr FW. The microvascular phases of metastasis. In Endothelial Cell Dysfunctions, Simionescu N, Simionescu M (eds). Plenum Press: New York, 1991; 455-475.
2. Hill GE, Whitten CW. The role of the vascular endothelium in inflammatory syndromes, atherogenesis, and the propagation of disease. J Cardiothorac Vasc Anesth 1997; 11: 316-321.
3. Glaves D, Huber RP, Weiss L. Hematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer 1988; 57: 32-35.
4. Glaves D. Detection of circulating metastatic cells in cancer metastasis. In Experimental and Clinical Strategies, Welch DR, Bluyan BK, Liotta LA (eds). Alan R. Liss: New York, 1986; 151-167.
5. Hellmann K. Entry of cancer cells into the vasculature. In Microcirculation in Cancer Metastasis, Orr FW, Buchanan MR, Weiss L (eds). CRC Press: Boca Raton, FL, 1991; 67-77.
6. Sugino T, Kawaguchi T, Suzuki T. Sequential process of blood-borne lung metastases of spontaneous mammary carcinoma in C3H mice. Int J Cancer 1993; 55: 141-147.
7. Meyer T, Hart IR. Mechanisms of tumour metastasis. Eur J Cancer 1998; 34: 214-221.
8. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149: 273-282.
9. Khokha R, Martin DC, Fata JE. Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors. Cancer Met Rev 1995; 14: 97-111.
10. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J, Riethmuller G. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 1990; 8: 831-837.
11. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992; 10: 1534-1539.
12. Pantel K, Izbicki JR. Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small cell lung cancer without overt metastases. Lancet 1996; 347: 649-653.
13. Israeli RS, Miller WH Jr, Su SL, et al. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol 1995; 153: 573-577.
14. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 1999; 91: 1113-1124.
15. Liotta LA, Kleinerman J, Saidel GM. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976; 36: 889-894.
16. Starkey R, Liggitt HD, Jones W, Hosick HL. Influence of migratory blood cells on the attachment of tumour cells to vascular endothelium. Int J Cancer 1984; 34: 535-543.
17. Weiss L, Nannmark U, Johansson BR, Bagge U. Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer 1992: 50: 103-107.
18. Weiss L, Dimitrov DS, Angelova M. The hemodynamic destruction of intravascular cancer cells in relation to myocardial metastasis. Proc Natl Acad Sci U S A 1985; 82: 5737-5741.
19. Weiss L. Principles of Metastasis. Academic Press: Orlando, FL, 1985; 1-425.
20. Pressman D, Yagi Y. Chemical differences in vascular beds. In Small Blood Vessel Involvement in Diabetes Mellitus, Colwell AR, Meyer K (eds). AIBS: Washington. DC, 1964; 177-183.
21. Auerbach R, Alby L, Morrissey W, Tu M, Joseph J. Expression of organ-specific antigens on capillary endothelial cells. Microvasc Res 1985; 29: 401-411.
22. Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 1980; 40: 2281-2287.
23. Azzarelli B, Easterling K, Norton JA. Leukemic cell endothelial cell interactions in leukemic cell dissemination. Lab Invest 1989; 60: 45-64.
24. Barbera-Guillem E, Vidal-Vanaclocha F. Selective involvement of a specific sinusoidal domain in hepatic metastasis. In Microcirculation in Cancer Metastasis, Orr FW, Buchanan MR, Weiss L (eds). CRC Press: Boca Raton, FL, 1991; 183-203.
25. Alonso-Varona A, Palomares T, Bilbao P, Calle Y, Castro B, Barbera-Guillem E. Tumor host interaction in non-random metastatic pattern distribution. Bull Cancer 1996; 83: 27-38.
26. Netland PA, Zetter BR. Organ-specific adhesion of metastatic tumor cells in vitro. Science 1984; 224: 1113-1115.
27. Brodt P. Tumor cell adhesion to frozen lymph node sections an in vitro correlate of lymphatic metastasis. Clin Exp Metastasis 1989; 7: 343-352.
28. Scherbarth S, Orr FW. Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1 on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res 1997; 57: 4105-4110.
29. Nicolson GL. Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells. Biochm Biophys Acta 1982; 695: 113-176.
30. Nicolson GL. Differential organ tissue adhesion, invasion, and growth properties of metastatic rat mammary adenocarcinoma cells. Breast Cancer Res Treat 1988; 12: 167-176.
31. Kostenuik PJ, Orr FW, Suyama K, Singh G. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Cancer Res 1993; 53: 5452-5457.
32. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 1: 571-573.
33. Nicolson GL. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988; 7: 143-188.
34. Pauli BU, Augustin Voss HG, el Sabban ME, Johnson RC, Hammer DA. Organ-preference of metastasis. The role of endothelial cell adhesion molecules. Cancer Metastasis Rev 1990; 9: 175-189.
35. Tang DG, Honn KV. Adhesion molecules and tumor metastasis: an update. Invasion Metastasis 1994; 14: 109-122.
36. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 1997; 14: 577-584.
37. Iwai K, Ishikura H, Kaji M, et al. Importance of E-selectin (ELAM-1) and sialyl Lewis (a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer 1993; 54: 972-977.
38. Lawrence MB, Smith CW, Eskin SG, McIntire LV. Effect of venous shear stress on CD18-mediated neutrophil adhesion to cultured endothelium. Blood 1990; 75: 227-237.
39. Kojima N, Shiota M, Sadahira Y, Handa K, Hakomori S. Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J Biol Chem 1992; 267: 17264-17270.
40. Giavazzi R, Foppolo M, Dossi R, Remuzzi A. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest 1993; 92: 3038-3044.
41. Brenner W, Langer P, Oesch F, Edgell CJ, Wieser RJ. Tumor cell-endothelium adhesion in an artificial venule. Anal Biochem 1995; 225: 213-219.
42. Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM, Byers SW. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer 1995; 60: 426-431.
43. Aigner S, Ramos CL, Hafezi-Moghadam A, et al. CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 1998; 12: 1241-1251.
44. Lafrenie RM, Podor TJ, Buchanan MR, Orr FW. Upregulated biosynthesis and expression of endothelial cell vitronectin receptor enhance cancer cell adhesion. Cancer Res 1992; 52: 2202-2208.
45. Lafrenie RM, Gallo S, Podor TJ, Buchanan MR, Orr FW. The relative roles of vitronectin receptor, E-selectin and alpha 4 beta 1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur J Cancer 1994; 30A: 2151-2158.
46. Okada T, Okuno H, Mitsui Y. A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells. Clin Exp Metastasis 1994; 12: 305-314.
47. Sandig M, Voura EB, Kalnins VI, Siu CH. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil Cytoskeleton 1997; 38: 351-364.
48. Voura EB, Sandig M, Siu CH. Cell-cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 1998; 43: 265-275.
49. Lewalle JM, Bajou K, Desreux J, et al. Alteration of interendothelial adherens junctions following tumor cell endothelial cell interaction in vitro. Exp Cell Res 1997; 237: 347-356.
50. 2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration. Clin Exp Metastasis 1998; 16: 21-29.
51. Anasagasti MJ, Olaso E, Calvo F, et al. Interleukin 1-dependent and -independent mouse melanoma metastases. J Natl Cancer Inst 1997; 89: 645-651.
52. Orosz P, Kruger A, Hubbe M, Ruschoff J, Von Hoegen P, Mannel DN. Promotion of experimental liver metastasis by tumor necrosis factor. Int J Cancer 1995; 60: 867-871.
53. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 1997; 71: 612-619.
54. Sato M, Narita T, Kimura N, et al. The association of sialyl Lewis (a) antigen with the metastatic potential of human colon cancer cells. Anticancer Res 1997; 17: 3505-3511.
55. Mannori G, Santoro D, Carter L, Corless C, Nelson RM, Bevilacqua MP. Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol 1997; 151: 233-243.
56. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996; 183: 581-587.
57. Araki M, Araki K, Biancone L, et al. The role of E-selectin for neutrophil activation and tumor metastasis in vivo. Leukemia 1997; 11 (Suppl 3): 209-212.
58. Kishimoto T, Saito K, Ishikura H [Mechanism of blood-borne metastasis in relation to the interaction between pancreatic carcinoma and endothelial cells]. Nippon Rinsho 1995; 53: 1765-1769.
59. Lauri D, Bertomeu MC, Orr FW, Bastida E, Sauder D, Buchanan MR. Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vivo and in vivo studies. Clin Exp Metastasis 1990; 8: 27-32.
60. Lafrenie RM, Gallo S, Podor TJ, Buchanan MR, Orr FW. The relative roles of vitronectin receptor, E-selectin and alpha4 beta1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur J Cancer 1994; 30A: 2151-2158.
61. Bertomeu MC, Gallo S, Lauri D, et al. Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression. Clin Exp Metastasis 1993; 11: 243-250.
62. Saiki I, Koike C, Obata A, et al. Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation. Int J Cancer 1996; 65: 833-839.
63. Higashiyama A, Watanabe H, Okumura K, Yagita H. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis. Cancer Immunol Immunother 1996; 42: 231-236.
64. Wood S. Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch Pathol 1958; 66: 550-568.
65. Elomaa I, Blomqvist C, Porkka L, et al. Clodronate for osteolytic metastases due to breast cancer. Biomed Pharmacother 1988; 42: 111-116.
66. Chambers AF, Schmidt EE, MacDonald IC, Morris VL, Groom AC. Early steps in hematogenous metastasis of B 16F1 melanoma cells in chick embryos studied by high-resolution intravial videomicroscopy. J Natl Cancer Inst 1992; 84: 797-803.
67. Morris VL, MacDonald IC, Koop S, Schmidt EE, Chambers AF, Groom AC. Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis 1993; 11: 377-390.
68. Chambers AF, MacDonald IC, Schmidt EE, et al. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev 1995; 14: 279-301.
69. Ley K, Bullard DC, Arbones ML, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995; 181: 669-675.
70. Thorlacius H, Prieto J, Raud J, et al. Tumor cell arrest in the microcirculation: lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo. Clin Immunol Immunopathol 1997; 83: 68-76.
71. Ye C, Kiriyama K, Mistuoka C, et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 1995; 61: 455-460.
72. Matsuura N, Narita T, Mitsuoka C, et al. Increased concentration of soluble E-selectin in the sera of breast cancer patients. Anticancer Res 1997; 17: 1367-1372.
73. Groves RW, Allen MH, Ross EL, Ahsan G, Barker JN, MacDonald DM. Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol 1993; 143: 1220-1225.
74. Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzki BM. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 1995; 87: 366-371.
75. Renkonen J, Paavonen T, Renkonen R. Endothelial and epithelial expression of sialyl Lewis (x) and sialyl Lewis (a) in lesions of breast carcinoma. Int J Cancer 1997; 74: 296-300.
76. Farmer RW, Richtsmeier WJ, Scher RL. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck 1998; 20: 726-731.
77. Matsuura N, Narita T, Mitsuoka C, et al. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. Jpn J Clin Oncol 1997; 27: 135-139.
78. Yamada N, Chung YS, Takatsuka S, et al. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br J Cancer 1997; 76: 582-587.
79. Martin-Satue M, Marrugat R, Cancelas JA, Blanco J. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res 1998; 58: 1544-1550.
80. Ravindranath MH, Amiri AA, Bauer PM, Kelley MC, Essner R, Morton DL. Endothelial-selectin ligands sialyl Lewis (x) and sialyl Lewis (a) are differentiation antigens immunogenic in human melanoma. Cancer 1997; 79: 1686-1697.
81. Albelda SM, Mette SA, Elder DE, et al. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990; 50: 6757-6764.
82. Nesbit M, Herlyn M. Adhesion receptors in human melanoma progression. Invasion Metastasis 1994; 14: 131-146.
83. Tomita Y, Saito T, Saito K, Oite T, Shimizu F, Sato S. Possible significance of VLA-4 (alpha 4 beta 1) for hematogenous metastasis of renal-cell cancer. Int J Cancer 1995; 60: 753-758.
84. Jin L, Yuan RQ, Fuchs A, et al. Expression of interleukin-1beta in human breast carcinoma. Cancer 1997; 80: 421-434.
85. Kurtzman SH, Anderson KH, Wang Y, et al. Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep 1999; 6: 65-70.
86. Narita T, Kawakami-Kimura N, Matsuura N, Hosono J, Kannagi R. Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells. Anticancer Res 1995; 15: 2523-2527.
87. Mendoza L, Olaso E, Anasagasti MJ, Fuentes AM, Vidal-Vanaclocha F. Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver. J Cell Physiol 1998; 174: 322-330.
88. Gangopadhyay A, Lazure DA, Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 1998; 16: 703-712.
89. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 1999; 59: 1356-1361.
90. Boehme MW, Waldherr R, Kist A, et al. Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF alpha therapy. Eur J Clin Invest 1996; 26: 404-410.
91. Brand K, Lubbe AS, Justus DJ. Hyperthermia decreases cytokine-mediated adhesion molecule expression on human umbilical vein endothelial cells. Int J Hyperthermia 1996; 12: 527-538.
92. Wang HH, Nance DM, Orr FW. Murine hepatic microvascular adhesion molecule expression is inducible and has a zonal distribution. Clin Exp Metastasis 1999; 17: 149-155.
93. Dhawan S, Singh S, Aggarwal BB. Induction of endothelial cell surface adhesion molecules by tumor necrosis factor is blocked by protein tyrosine phosphatase inhibitors: role of the nuclear transcription factor NF-kappa B. Eur J Immunol 1997; 27: 2172-2179.
94. Sheski FD, Natarajan V, Pottratz ST. Tumor necrosis factor-alpha stimulates attachment of small cell lung carcinoma to endothelial cells. J Lab Clin Med 1999; 133: 265-273.
95. Sato M, Narita T, Kawakami-Kimura N, et al. Increased expression of integrins by heparin-binding EGF like growth factor in human esophageal cancer cells. Cancer Lett 1996; 102: 183-191.
96. Narita T, Kawakami-Kimura N, Sato M, et al. Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology 1996; 53: 374-381.
97. Kawakami-Kimura N, Narita T, Ohmori K, et al. Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br J Cancer 1997; 75: 47-53.
98. Orr FW, Buchanan MR, Tron VA, Guy D, Lauri D, Sauder DN. Chemotactic activity of endothelial cell-derived interleukin-1 for human tumor cells. Cancer Res 1988; 48: 6758-6763.
99. Wakabayashi H, Cavanaugh PG, Nicolson GL. Purification and identification of mouse lung microvessel endothelial cell-derived chemoattractant for lung-metastasizing murine RAW117 large-cell lymphoma cells: identification as mouse monocyte chemotactic protein 1. Cancer Res 1995; 55: 4458-4464.
100. Pluda JM. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol 1997; 24: 203-218.
101. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression [see comments]. Nature Med 1995; 1: 149-153.
102. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 1998; 93: 661-664.
103. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-66.
104. Folkman J. Is tissue mass regulated by vascular endothelial cells?. Prostate as the first evidence. Endocrinology 1998; 139: 441-442.
105. Rak JW, St Croix BD, Kerbel RS. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 1995; 6: 3-18.
106. Tang DG, Diglio CA, Honn KV. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of zvβ3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process. Cancer Res 1994; 54: 1119-1129.
107. Honn KV, Tang DG, Grossi IM, et al. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res 1994; 54: 565-574.
108. Honn KV, Tang DG. Grossi IM, et al. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 1994; 210: 1-9.
109. Horrobin DF, Ziboh VA. The importance of linoleic acid metabolites in cancer metastasis and in the synthesis and actions of 13-HODE. Adv Exp Med Biol 1997; 433: 291-294.
110. Bastida E, Almirall L, Ordinas A, et al. Effects of endothelial cell treatment on 13-HODE and prostacyclin synthesis and its correlation with tumor cell vascular endothelial cell adhesion. Invasion Metastasis 1991; 11: 273-280.
111. Buchanan MR, Bertomeu MC, Haas TA, Orr FW, Eltringham-Smith LL. Localization of 13-hydroxyoctadecandienoic acid and the vitronectin receptor in human endothelial cells and endothelial cell/platelet interactions in vitro. Blood 1993; 81: 3303-3312.
112. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997; 11: 118-124.
113. Warner HR. Superoxide dismutase, aging, and degenerative disease. Free Radic Biol Med 1994; 17: 249-258.
114. Malisza KL, McIntosh AR, Sveinson SE, Hasinoff BB. Semiquinone free radical formation by daunorubicin aglycone incorporated into the cellular membranes of intact Chinese hamster ovary cells. Free Radic Res 1996; 24: 9-18.
115. Lazo JS, Sebti SM, Schellens JH. Bleomycin. Cancer Chemother Biol Response Modif 1996; 16: 39-47.
116. Hensley K, Carney J, Hall N, Shaw W, Butterfield DA. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure. Free Radic Biol Med 1994; 17: 321-331.
117. Knight JA. Diseases related to oxygen-derived free radicals. Ann Clin Lab Sci 1995; 25: 111-121.
118. Adamson IYR, Young L, Orr FW. Tumor metastasis after hyperoxic injury and repair of the pulmonary endothelium. Lab Invest 1987; 57: 71-77.
119. Orr FW, Adamson IYR, Young L. Promotion of pulmonary metastasis in mice by bleomycin-induced endothelial injury. Cancer Res 1986; 46: 891-897.
120. Adamson IYR, Orr FW, Young L. Effects of injury and repair of the pulmonary endothelium on lung metastasis after bleomycin. J Pathol 1986: 150: 279-287.
121. Orr FW, Warner DJA. Effects of neutrophil-mediated pulmonary endothelial injury on the localization and metastasis of circulating Walker carcinosarcoma cells. Invasion Metastasis 1987; 7: 183-196.
122. Orr FW, Warner DJA. Effects of systemic complement activation and neutrophil-mediated pulmonary injury on the retention and metastasis of circulating cancer cells in mouse lungs. Lab Invest 1990; 62: 331-338.
123. Vincic L, Orr FW, Warner DJA, Suyama KL, Kay JM. Enhanced cancer metastasis after monocrotaline-induced lung injury. Toxicol Appl Pharmacol 1989; 100: 259-270.
124. Lafrenie R, Shaughnessy SG, Orr FW. Cancer cell interactions with injured or activated endothelium. Cancer Metastasis Rev 1992; 11: 377-388.
125. Simpkins H, Lehman JM, Mazurkiewicz JE, Davis BH. A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 1991; 51: 1334-1338.
126. Rayner DC, Orr FW, Shiu RPC. Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells. Cancer Res 1985; 45: 2288-2293.
127. Wass JA, Varani J, Piontek GE, Goff D, Ward PA. Characteristics of the chemotactic factor-mediated cell swelling response of tumor cells. J Natl Cancer Inst 1981; 66: 927-933.
128. Leroyer V, Werner L, Shaughnessy S, Goddard GJ, Orr FW. Chemiluminescence and oxygen radical generation by Walker carcinosarcoma cells following chemotactic stimulation. Cancer Res 1987; 47: 4771-4775.
129. 2 release by human blood monocytes and mouse peritoneal macrophages. J Immunol Methods 1985; 78: 323-336.
130. Soares FA, Shaughnessy SG, MacLarkey WR, Orr FW. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo. Lab Invest 1994; 71: 480-489.
131. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51: 794-798.
132. Shaughnessy SG, Buchanan MR, Turple S, Richardson M, Orr FW. Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species. Am J Pathol 1989; 134: 787-796.
133. Vissers MCM. Neutrophils adherent to a nonphagocytosable surface (glomerular basement membrane) produce oxidants only at the site of attachment. Blood 1985; 66: 161-166.
134. Shaughnessy SG, Lafrenie RM, Buchanan MR, Podor TJ, Orr FW. Endothelial cell damage by Walker carcinosarcoma cells is dependent upon vitronectin receptor-mediated tumor cell adhesion. Am J Pathol 1991; 138: 1535-1543.
135. Offner FA, Schiefer J, Wirtz HC, et al. Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage. Virchows Arch 1996; 428: 99-106.
136. 2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion. J Cell Physiol 1996; 167: 314-323.
137. Anasagasti MJ, Alvarez A, Martin JJ, Mendoza L, Vidal-Vanaclocha F. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice. Hepatology 1997; 25: 840-846.
138. Andreoli SP, Mallett CP, Bergstein JM. Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 1986; 108: 190.
139. Garcia JGN, Dodson RF, Callahan KS. Effect of environmental particulates on cultured human and bovine endothelium. Cellular injury via an oxidant-dependent pathway. Lab Invest 1989; 61: 53-61.
140. Varani J, Ginsburg I, Schuger L, et al. Rapid communication. Endothelial cell killing by neutrophils. Am J Pathol 1989; 135: 435-438.
141. Missirlis E, Whaley M, Lhotak S, Orr FW. Endothelial injury causes degradation of adjacent basement membranes and promotes their invasion by A549 carcinoma cells. Invasion Metastasis 1992; 12: 35-46.
142. Missirlis E, Whaley M, Lhotak S, Orr FW. Endothelial injury causes degradation of adjacent basement membranes and promotes their invasion by A549 carcinoma cells. Invasion Metastasis 1992; 12: 35-46.
143. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-kappa B and AP-1 in endothelial cells. Am J Physiol 1995; 269: L829-L836.
144. Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA. Hydrogen peroxide stimulates the synthesis of platelet-activity factor by endothelium and induces endothelium cell-dependent neutrophil adhesion. J Clin Invest 1988; 82: 2045-2055.
145. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991; 112: 749-759.
146. Shatos MA, Doherty JM, Orfeo T, Hoak JC, Collen D, Stump DC. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J Biol Chem 1992; 267: 597-601.
147. 2 exposure. Lab Invest 1997; 77: 533-539.
148. Shaughnessy SG, Whaley M, Lafrenie RM, Orr FW. Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch Biochem Biophys 1993; 304: 314-321.
149. Kong L, Dunn GD, Keefer LK, Korthuis RJ. Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin Exp Metastasis 1996; 14: 335-343.
150. Geng Y, Hellstrand K, Wennmalm A, Hansson GK. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α. Cancer Res 1996; 56: 866-874.
151. Murata J, Corradin SB, Janzer RC, Juillerat Jeanneret L. Tumor cells suppress cytokine-induced nitric-oxide (NO) production in cerebral endothelial cells. Int J Cancer 1994; 59: 699-705.
152. Chang MJ, Modzelewski RA, Russell DM, Johnson CS. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells. Cancer Res 1996; 56: 886-891.
153. Rocha M, Kruger A, Van Rooijen N, Schirrmacher V, Umansky V. Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int J Cancer 1995; 63: 405-411.
154. Denhardt DT, Chambers AF. Overcoming obstacles to metastasis - defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 1994; 56: 48-51.
155. Scherbarth S, Orr FW. Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1 on metastasis and the location of B 16F1 melanoma cell arrest. Cancer Res 1997; 57: 4105-4110.
156. Thurman RG, Ley HG, Scholz R. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur J Biochem 1972; 25: 420-430.
157. 2 exposure. Lab Invest 1997; 77: 533-539.
158. Tozawa K, Sakurada S, Kohri K, Okamoto T. Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res 1995; 55: 4162-4167.
159. Ye C, Kiriyama K, Mistuoka C, et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 1995; 61: 455-460.
160. Steinbach F, Tanabe K, Alexander J, et al. The influence of cytokines on the adhesion of renal cancer cells to endothelium. J Urol 1996; 155: 743-748.
161. Majuri ML, Hakkarainen M, Paavonen T, Renkonen R. Carcinoembryonic antigen is expressed on endothelial cells. A putative mediator of tumor cell extravasation and metastasis. APMIS 1994; 102: 432-438.
162. Tamaki M, Aoyagi M, Morita I, Hirakawa K, Murota S. Cell adhesion molecules acting between C6 glioma and endothelial cells. J Neurooncol 1995; 24: 181-188.
163. Tomita Y, Saito T, Saito K, Oite T, Shimizu F, Sato S. Possible significance of VLA-4 (alpha 4 beta 1) for hematogenous metastasis of renal-cell cancer. Int J Cancer 1995; 60: 753-758.
164. Taichman DB, Cybulsky MI, Djaffar I, et al. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul 1991; 2: 347-355.
165. Garofalo A, Chirivi RG, Foglieni C, et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1 augmented experimental metastases. Cancer Res 1995; 55: 414-419.
166. Paavonen T, Tiisala S, Majuri ML, Bohling T, Renkonen R. In vivo evidence of the role of alpha 4 beta 1 VCAM-1 interaction in sarcoma, but not in carcinoma extravasation. Int J Cancer 1994; 58: 298-302.
167. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, et al. Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993; 54: 793-806.
168. Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994; 54: 2514-2520.
169. Piali L, Hammel P, Uherek C, et al. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol 1995; 130: 451-460.
170. Ruiz P, Dunon D, Sonnenberg A, Imhof BA. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins. Cell Adhes Commun 1993; 1: 67-81.
171. Incardona F, Lewalle JM, Morandi V, et al. Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Cancer Res 1995; 55: 166-173.
172. Zocchi MR, Vidal M, Poggi A. Involvement of CD56/N-CAM molecule in the adhesion of human solid tumor cell lines to endothclial cells. Exp Cell Res 1993; 204: 130-135.
173. Johnson RC, Zhu D, Augustin Voss HG, Pauli BU. Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells. J Cell Biol 1993; 121: 1423-1432.